Mannose immunogens for hiv-1

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/21 (2006.01) C07K 14/16 (2006.01) C12N 7/00 (2006.01) C12P 1/02 (2006.01) C12P 21/02 (2006.01)

Patent

CA 2601797

Methods of producing a carbohydrate HIV vaccine or immunogenic composition are provided. One method comprises expressing a glycoprotein with a modified glycosylation, which facilitates binding of the glycoprotein to the 2Gl 2 antibody. Another method comprises iteratively selecting cells with a high affinity for the 2Gl 2 antibody.

L'invention porte sur des procédés de fabrication d'un vaccin anti-HIV de glucide ou d'une composition immunogène. Un procédé consiste à exprimer une glycoprotéine présentant une glycosylation modifiée, ce qui facilite la liaison de la glycoprotéine à l'anticorps 2G12. Un autre procédé consiste à sélectionner de manière itérative des cellules présentant une affinité élevée avec l'anticorps 2G12.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mannose immunogens for hiv-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mannose immunogens for hiv-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mannose immunogens for hiv-1 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1765063

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.